Researcher.Life Logo

IUBMB Life : Impact Factor & More

eISSN: 1521-6551pISSN: 1521-6543

Key Metrics

CiteScore
7.1
Eigenfactor
0.005 - 0.01
H-Index
125
Impact Factor
< 5
SJR
Q1Genetics
SNIP
0.95
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on IUBMB Life

IUBMB Life Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1999
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in IUBMB Life ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in IUBMB Life

Low SFXN1 Expression Predicts Poor Clinical Outcomes and Promotes Tumor Aggressiveness in Colon Adenocarcinoma.
  • 1 May 2026
  • IUBMB life
Lipo-Glc-1,6-P2: A Bioprecursor Prodrug for Phosphomannomutase-2 Congenital Disorder of Glycosylation.
  • 1 Apr 2026
  • IUBMB life
CYP17A1 Locus: Regulatory Mechanisms and Clinical Associations With Cardiovascular Disease and Metabolic Syndrome.
  • 1 Apr 2026
  • IUBMB life
Self-Assembled Nanovaccines: A Promising Strategy for Overcoming Influenza Variability and Advancing Universal Vaccine Development.
  • 1 Apr 2026
  • IUBMB life
HIF Signalling Modulates p53/miR-145-5p Axis in Hypoxia-Driven Tumorigenesis of HepG2 Tumourspheres.
  • 1 Apr 2026
  • IUBMB life
Hypoxia-Inducible Factors as Guardians of Cancer Stem Cell Fate: Implications for Novel Therapies.
  • 1 Apr 2026
  • IUBMB life
Low SFXN1 Expression Predicts Poor Clinical Outcomes and Promotes Tumor Aggressiveness in Colon Adenocarcinoma.
  • 1 May 2026
  • IUBMB life
Lipo-Glc-1,6-P2: A Bioprecursor Prodrug for Phosphomannomutase-2 Congenital Disorder of Glycosylation.
  • 1 Apr 2026
  • IUBMB life
CYP17A1 Locus: Regulatory Mechanisms and Clinical Associations With Cardiovascular Disease and Metabolic Syndrome.
  • 1 Apr 2026
  • IUBMB life
Self-Assembled Nanovaccines: A Promising Strategy for Overcoming Influenza Variability and Advancing Universal Vaccine Development.
  • 1 Apr 2026
  • IUBMB life
HIF Signalling Modulates p53/miR-145-5p Axis in Hypoxia-Driven Tumorigenesis of HepG2 Tumourspheres.
  • 1 Apr 2026
  • IUBMB life
Hypoxia-Inducible Factors as Guardians of Cancer Stem Cell Fate: Implications for Novel Therapies.
  • 1 Apr 2026
  • IUBMB life

FAQs on IUBMB Life